Symplocos cochinchinensis subsp. leptophylla
Symplocos cochinchinensis subsp. leptophylla · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Symplocos cochinchinensis subsp. leptophylla is a botanical species recognized for its diverse pharmacological potential. Within traditional medicinal practices, this plant is specifically utilized for its potent analgesic activities. It serves as a natural resource for addressing various types of physical pain. To harness these therapeutic benefits, researchers and practitioners primarily utilize specialized plant extracts. Understanding the properties of this subspecies is essential for exploring its role in pain management.
- Synonyms
- Symplocos Leptophylla · Symplocos Palmarum · 8 more
- Common names
- Not available
- Family
- Symplocaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Symplocos cochinchinensis subsp. leptophylla is a botanical taxon that is frequently identified through various synonymous names in scientific literature. Researchers may encounter this plant under several different designations, such as Symplocos aggregata or Symplocos luteifolia. It is also recognized by its varietal and form-based names, including Symplocos cochinchinensis var. leptophylla and Symplocos leptophylla f. compacta. Furthermore, the simpler designation of Symplocos leptophylla serves as another valid synonym for this specific subspecies. Understanding these taxonomic relationships is essential for ensuring accuracy when documenting the plant's biodiversity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Symplocos cochinchinensis subsp. leptophylla is a unique botanical specimen belonging to the vast kingdom Plantae. This specific plant is classified under the class Equisetopsida, showcasing its specialized biological traits. Within this grouping, it falls under the order Ericales, connecting it to a diverse range of related species. It is a distinguished member of the genus Symplocos, which defines its structural characteristics. Finally, its lineage is completed by its placement within the family Symplocaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Symplocaceae |
| Genus | Symplocos |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Symplocos cochinchinensis subsp. leptophylla exhibits a broad and fascinating distribution across several key regions of the tropical world. It is prominently found within the Malesia region, specifically across the Maluku islands in Asia-Tropical zones. The subspecies also spans much of Papuasia, including the Bismarck Archipelago, New Guinea, and the Solomon Islands. Moving further into the Pacific, its presence extends to the Southwestern Pacific, notably reaching the islands of Fiji. This wide geographic range highlights the plant's ability to thrive within diverse island ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Symplocos cochinchinensis subsp. leptophylla has demonstrated significant potential as a source of analgesic compounds through recent scientific investigation. Researchers evaluated various ethnomedicinally selected plants to determine if they possessed biological activity relevant to pain relief. By utilizing in vitro receptor radioligand binding assays, the study specifically examined interactions with receptors like Bradykinin, neurokinin 1, and calcitonin gene-related peptide. The findings indicated that certain plant extracts, including those from the Symplocos genus, showed a strong indication of activity in mediating acute pain. This research highlights how traditional medicinal knowledge can be validated through targeted molecular assays to identify selective pain-relieving agents.
Compounds
Conditions
Symplocos cochinchinensis subsp. leptophylla, referred to in the research as Symplocos leptophylla, is recognized for its traditional ethnomedicinal use in the relief of pain. This plant was specifically selected for investigation due to its potential as a source of analgesic compounds. Scientific testing involved preparing extracts to evaluate their biological activity through receptor radioligand binding assays. The study focused on how such extracts interact with neuropeptide receptors like Bradykinin, neurokinin 1, and CGRP, which are implicated in acute pain. Ultimately, the research provided a strong indication of biological activity for this species in its capacity to treat pain.
Preparations
Symplocos cochinchinensis subsp. leptophylla is prepared as extracts to investigate its potential as a source of analgesic compounds. These specific preparations were subjected to three different in vitro receptor radioligand binding assays. The testing focused on determining whether the plant's biological activity showed selectivity toward receptors implicated in acute pain mediation. Specifically, the research examined interactions with Bradykinin, neurokinin 1, and calcitonin gene-related peptide receptors. Ultimately, these extracts were evaluated to see if they exhibited the selective action necessary to relieve pain in the mammalian central nervous system.